BioBusiness

Articles

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.

Pfizer has completed its acquisition of Biohaven Pharmaceuticals for approximately $11.6 billion.

Actylis combines Aceto and its 10 acquired specialists into a singular global brand.

Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.


ChargePoint Technology has acquired single-use container company PuroVaso.

Catalent will acquire Metrics Contract Services for $475 million to expand high-potent capabilities and oral development and manufacturing capacity.

Amgen’s acquisition of Chemocentryx includes the autoimmune disease drug Tavneos (avacopan).

CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.

Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.